Male breast cancer after finasteride therapy for benign prostate hyperplasia

Jui Ming Liu; Yang Jen Chiang; Chen Lin Chi; Yung Feng Lo; Chih Yuan Chou

doi:10.1016/j.urols.2012.06.001

Male breast cancer after finasteride therapy for benign prostate hyperplasia

Jui Ming Liu, Yang Jen Chiang, Chen Lin Chi, Yung Feng Lo, Chih Yuan Chou

Research output: Contribution to journal › Article › peer-review

Abstract

Finasteride has been used for the treatment of benign prostate hyperplasia (BPH) for years, but some side effects, including male breast cancer (MBC), have been reported. We report a case of breast cancer in a male patient who received finasteride therapy for BPH, and to our knowledge, our report is believed to be the first in Taiwan. The patient was a 59-year-old man who received finasteride therapy for BPH for 4years. He found a palpable mass in his left breast 2 months prior to diagnosis. Ultrasound-guided core biopsy showed invasive ductal carcinoma. A simple mastectomy was performed followed by chemotherapy with tamoxifen.

Original language	English
Pages (from-to)	127-128
Number of pages	2
Journal	Urological Science
Volume	24
Issue number	4
DOIs	https://doi.org/10.1016/j.urols.2012.06.001
Publication status	Published - Dec 2013
Externally published	Yes

Keywords

Benign prostate hyperplasia
Finasteride
Male breast cancer

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.urols.2012.06.001

Cite this

@article{a3d319621f614fbd9cb43b6894adfe8e,

title = "Male breast cancer after finasteride therapy for benign prostate hyperplasia",

abstract = "Finasteride has been used for the treatment of benign prostate hyperplasia (BPH) for years, but some side effects, including male breast cancer (MBC), have been reported. We report a case of breast cancer in a male patient who received finasteride therapy for BPH, and to our knowledge, our report is believed to be the first in Taiwan. The patient was a 59-year-old man who received finasteride therapy for BPH for 4years. He found a palpable mass in his left breast 2 months prior to diagnosis. Ultrasound-guided core biopsy showed invasive ductal carcinoma. A simple mastectomy was performed followed by chemotherapy with tamoxifen.",

keywords = "Benign prostate hyperplasia, Finasteride, Male breast cancer",

author = "Liu, {Jui Ming} and Chiang, {Yang Jen} and Chi, {Chen Lin} and Lo, {Yung Feng} and Chou, {Chih Yuan}",

year = "2013",

month = dec,

doi = "10.1016/j.urols.2012.06.001",

language = "English",

volume = "24",

pages = "127--128",

journal = "Urological Science",

issn = "1879-5226",

publisher = "Wolters Kluwer Medknow Publications",

number = "4",

}

TY - JOUR

T1 - Male breast cancer after finasteride therapy for benign prostate hyperplasia

AU - Liu, Jui Ming

AU - Chiang, Yang Jen

AU - Chi, Chen Lin

AU - Lo, Yung Feng

AU - Chou, Chih Yuan

PY - 2013/12

Y1 - 2013/12

N2 - Finasteride has been used for the treatment of benign prostate hyperplasia (BPH) for years, but some side effects, including male breast cancer (MBC), have been reported. We report a case of breast cancer in a male patient who received finasteride therapy for BPH, and to our knowledge, our report is believed to be the first in Taiwan. The patient was a 59-year-old man who received finasteride therapy for BPH for 4years. He found a palpable mass in his left breast 2 months prior to diagnosis. Ultrasound-guided core biopsy showed invasive ductal carcinoma. A simple mastectomy was performed followed by chemotherapy with tamoxifen.

AB - Finasteride has been used for the treatment of benign prostate hyperplasia (BPH) for years, but some side effects, including male breast cancer (MBC), have been reported. We report a case of breast cancer in a male patient who received finasteride therapy for BPH, and to our knowledge, our report is believed to be the first in Taiwan. The patient was a 59-year-old man who received finasteride therapy for BPH for 4years. He found a palpable mass in his left breast 2 months prior to diagnosis. Ultrasound-guided core biopsy showed invasive ductal carcinoma. A simple mastectomy was performed followed by chemotherapy with tamoxifen.

KW - Benign prostate hyperplasia

KW - Finasteride

KW - Male breast cancer

UR - http://www.scopus.com/inward/record.url?scp=84889594220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889594220&partnerID=8YFLogxK

U2 - 10.1016/j.urols.2012.06.001

DO - 10.1016/j.urols.2012.06.001

M3 - Article

AN - SCOPUS:84889594220

SN - 1879-5226

VL - 24

SP - 127

EP - 128

JO - Urological Science

JF - Urological Science

IS - 4

ER -

Male breast cancer after finasteride therapy for benign prostate hyperplasia

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this